Patients with severe iron overload may develop hepatic fibrosis due to
iron toxicity. Unfortunately, the follow-up of the fibrogenic activit
y during treatment by histological examination of tissue biopsies carr
ies potential side effects, and may therefore not be justified ethical
ly. Recently, the serum concentration of procollagen type III peptide
(S-PIIINP) has been shown to be a valid serum marker of the activity o
f collagen metabolism in conditions with hepatic fibrosis unrelated to
iron overload. In order to evaluate the potential usefulness of this
test in patients with fibrosis due to iron overload, we investigated t
he relationship between the PIIINP serum concentration and the size of
iron overload in 18 patients with hereditary haemochromatosis (HH) an
d in 14 patients with transfusional iron overload. A close correlation
was found between S-ferritin and S-PIIINP (r=0.73, p<0.0001). Follow-
up of 6 patients during iron depletion treatment revealed a normalizat
ion of the serum aminotransferase concentration before normalization o
f S-PIIINP was found. This may indicate that excess iron directly indu
ces an increase in fibrogenesis rather than the increased fibrogenesis
is secondary to hepatocellular injury caused by iron excess. Thus, se
rial measurements S-PIIINP may be useful in follow-up of the fibrogeni
c process due to iron overload.